- Home
- PCVX vs CELH Comparison
PCVX vs CELH Comparison
Compare PCVX & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- CELH
- Stock Information
- Founded
- PCVX 2013
- CELH 2004
- Country
- PCVX United States
- CELH United States
- Employees
- PCVX N/A
- CELH N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- CELH Beverages (Production/Distribution)
- Sector
- PCVX Health Care
- CELH Consumer Staples
- Exchange
- PCVX Nasdaq
- CELH Nasdaq
- Market Cap
- PCVX 12.5B
- CELH 8.9B
- IPO Year
- PCVX 2020
- CELH N/A
- Fundamental
- Price
- PCVX $114.24
- CELH $33.18
- Analyst Decision
- PCVX Strong Buy
- CELH Strong Buy
- Analyst Count
- PCVX 7
- CELH 16
- Target Price
- PCVX $147.50
- CELH $58.60
- AVG Volume (30 Days)
- PCVX 1.4M
- CELH 5.3M
- Earning Date
- PCVX 11-04-2024
- CELH 11-05-2024
- Dividend Yield
- PCVX N/A
- CELH N/A
- EPS Growth
- PCVX N/A
- CELH N/A
- EPS
- PCVX N/A
- CELH 1.02
- Revenue
- PCVX N/A
- CELH $1,489,877,000.00
- Revenue This Year
- PCVX N/A
- CELH $17.90
- Revenue Next Year
- PCVX N/A
- CELH $18.34
- P/E Ratio
- PCVX N/A
- CELH $32.59
- Revenue Growth
- PCVX N/A
- CELH 56.50
- 52 Week Low
- PCVX $44.20
- CELH $31.55
- 52 Week High
- PCVX $119.50
- CELH $99.62
- Technical
- Relative Strength Index (RSI)
- PCVX 76.88
- CELH 33.00
- Support Level
- PCVX $112.55
- CELH $32.04
- Resistance Level
- PCVX $117.39
- CELH $35.36
- Average True Range (ATR)
- PCVX 4.48
- CELH 1.79
- MACD
- PCVX 1.90
- CELH 0.20
- Stochastic Oscillator
- PCVX 87.56
- CELH 18.21
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages (including those that are naturally caffeinated with stevia), Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.